A review of approaches to viral chemotherapy.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D004353:Drug Evaluation, Preclinical; D006571:Heterocyclic Compounds / Q000627:therapeutic use; D006801:Humans; D007369:Interferon Inducers / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use; D009705:Nucleosides / Q000627:therapeutic use; D009858:Oncogenic Viruses / Q000502:physiology; D011083:Polycyclic Compounds / Q000627:therapeutic use; D014777:Virus Diseases / Q000188:drug therapy* / Q000382:microbiology / Q000401:mortality / Q000628:therapy; D018406:Virus Physiological Phenomena; D014780:Viruses / Q000187:drug effects
D000276:Adjuvants, Immunologic; D000998:Antiviral Agents; D006571:Heterocyclic Compounds; D007369:Interferon Inducers; D009705:Nucleosides; D011083:Polycyclic Compounds; D007372:Interferons